KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $992.3 million.

  • Neogenomics' Non-Current Assets fell 5.57% to $992.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $992.3 million, marking a year-over-year decrease of 5.57%. This contributed to the annual value of $1.0 billion for FY2024, which is 3.91% down from last year.
  • Per Neogenomics' latest filing, its Non-Current Assets stood at $992.3 million for Q3 2025, which was down 0.91% from $1.0 billion recorded in Q2 2025.
  • Neogenomics' 5-year Non-Current Assets high stood at $1.2 billion for Q3 2021, and its period low was $551.7 million during Q1 2021.
  • Its 3-year average for Non-Current Assets is $1.1 billion, with a median of $1.1 billion in 2024.
  • As far as peak fluctuations go, Neogenomics' Non-Current Assets skyrocketed by 123.09% in 2021, and later declined by 5.57% in 2025.
  • Neogenomics' Non-Current Assets (Quarterly) stood at $1.2 billion in 2021, then declined by 4.50% to $1.1 billion in 2022, then dropped by 4.44% to $1.1 billion in 2023, then decreased by 3.91% to $1.0 billion in 2024, then dropped by 5.57% to $992.3 million in 2025.
  • Its Non-Current Assets stands at $992.3 million for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.